← Back to Search

Respiratory Training for Lymphoma Survivors

N/A

Recruiting

Led By Ryan Marker, PT, PhD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial shows IMST is an effective 5min/day exercise to improve cardiovascular health & exercise tolerance. It may help those unable to exercise.

Who is the study for?

This trial is for lymphoma survivors aged 18-80 who've completed cancer treatment over a year ago, can exercise, and have a smartphone to use the training app. It's not for those with significant health issues like severe diabetes, heart disease, or unstable weight, nor for those doing lots of regular exercise already.Check my eligibility

What is being tested?

The study tests high-resistance inspiratory muscle strength training (IMST) using a handheld device against a sham version. IMST could improve cardiovascular health and exercise tolerance in just about 5 minutes per day.See study design

What are the potential side effects?

While specific side effects are not listed here, IMST may cause discomfort due to increased breathing resistance during training sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Enrolled Participants per Month

Session Attendance per Participant

Systolic Blood Pressure

+3 more

Secondary outcome measures

Cardiac risk factors will be collected from medical history forms

Cardiorespiratory Fitness (CRF) will be assessed via estimated VO2max

Functional Assessment of Cancer Therapy - General (FACT-G, assessing quality of life)

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Lymphoma Survivors sham IMSTExperimental Treatment1 Intervention

Participants will undergo a version of the BfitBwell Cancer Exercise Program physical assessment, which assesses physical fitness and function.

Group II: Lymphoma Survivors IMSTExperimental Treatment1 Intervention

Participants will undergo a version of the BfitBwell Cancer Exercise Program physical assessment, which assesses physical fitness and function.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Inspiratory muscle strength training

2018

N/A

~160

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,502 Total Patients Enrolled

Ryan Marker, PT, PhDPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

Lymphoma Survivors sham IMST Clinical Trial Eligibility Overview. Trial Name: NCT05938127 — N/A

Non-Hodgkin's Lymphoma Research Study Groups: Lymphoma Survivors sham IMST, Lymphoma Survivors IMST

Non-Hodgkin's Lymphoma Clinical Trial 2023: Lymphoma Survivors sham IMST Highlights & Side Effects. Trial Name: NCT05938127 — N/A

Lymphoma Survivors sham IMST 2023 Treatment Timeline for Medical Study. Trial Name: NCT05938127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does your research project admit participants aged eighty and above?

"This clinical trial requires prospective participants to fall between 18 and 80 years old, as stipulated by its eligibility criteria."

Answered by AI

Are there any criteria which must be met to participate in this research?

"Eligibility requirements for this clinical trial mandate that patients are between 18 and 80 years old, with a diagnosis of Hodgkin's lymphoma. Our research team is seeking 24 participants in total."

Answered by AI

Are there any available slots left to join this research study?

"According to the information supplied on clinicaltrials.gov, this clinical trial is no longer seeking participants, as its last update was made June 30th 2023. Nevertheless, there are still 1737 other trials that require volunteers right now."

Answered by AI

What is the primary purpose of this clinical investigation?

"The primary metric of this five-month clinical trial is the Total Participants Recruited. Additionally, Secondary outcomes such as Cardiorespiratory Fitness (CRF) will be measured through an estimated VO2max which utilizes a Tecumseh Step Test to record heart rate post-exercise and calculate an individual's predicted oxygen consumption. Physical function is primarily evaluated via the 6 Minute Walk Test, while Metabolomics analysis on blood samples collected during standardized aerobic exercise sessions are performed using Tasso+ devices for patient comfortability."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Respiratory Training in Lymphoma Survivors

2024. "Impact of Respiratory Training in Lymphoma Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05938127.